Gallagher Fiduciary Advisors’s Boston Scientific BSX Stock Holding History

Gallagher Fiduciary Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$523K	Buy	8,329 +413	+5%	+$33K	0.02%	152
2025 Q4	$755K	Buy	7,916 +403	+5%	+$39.5K	0.02%	131
2025 Q3	$733K	Buy	7,513 +141	+2%	+$14.6K	0.03%	104
2025 Q2	$792K	Buy	7,372 +263	+4%	+$26.6K	0.03%	105
2025 Q1	$717K	Buy	7,109 +124	+2%	+$12.5K	0.02%	122
2024 Q4	$624K	Buy	6,985 +802	+13%	+$70.6K	0.12%	112
2024 Q3	$518K	Buy	6,183 +1,297	+27%	+$102K	0.1%	112
2024 Q2	$376K	Buy	4,886 +1,798	+58%	+$132K	0.08%	127
2024 Q1	$211K	Buy	+3,088	New	+$199K	0.01%	184

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gallagher Fiduciary Advisors's BSX Position: Q1 2026 in Review

Gallagher Fiduciary Advisors increased its Boston Scientific (BSX) stake by 5.2% in Q1 2026, buying an estimated $33K and bringing the position to 8,329 shares worth $523K. The position accounts for 0.02% of the portfolio, ranked #152.

Gallagher Fiduciary Advisors first reported a position in BSX in Q1 2024 and has held it in 9 quarters since. The position peaked at $792K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Gallagher Fiduciary Advisors held 8,329 shares of Boston Scientific worth $523K as of Q1 2026.
Gallagher Fiduciary Advisors bought 413 Boston Scientific shares in Q1 2026, an estimated $33K.
Boston Scientific made up 0.02% of Gallagher Fiduciary Advisors's portfolio in Q1 2026, its #152 holding.
Gallagher Fiduciary Advisors first reported a position in Boston Scientific in Q1 2024 and has held it in 9 quarters since.
Gallagher Fiduciary Advisors's Boston Scientific position peaked at $792K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q1 2026, filed 15 May 2026.